Chondroblastic osteosarcoma of the proximal left tibia in the setting of cystic fibrosis related diabetes mellitus. Clinical case
DOI:
https://doi.org/10.15574/PP.2023.93.123Keywords:
children, chondroblastic osteosarcoma, cystic fibrosis related diabetesAbstract
Cystic fibrosis related diabetes (CFRD) is a rare pathology that combines genetically determined systemicity with damage to the exocrine glands, which leads to early manifestations of the disease, a clear exacerbation and chronicity of the process, with possible complications in bone remodeling with the occurrence of malignant tumors.
Purpose - to acquaint practitioners with the peculiarities of manifestations, diagnosis and course of chondroblastic osteosarcoma in a child with CFRD.
Features of the clinical course and differential diagnosis are described and given osteosarcoma of the proximal part of the left tibia against the background of CFRD in a child. The main diagnostic value of history, clinical picture, laboratory, instrumental, immunohistochemical and microscopic research methods was highlighted, in particular, a biopsy of this tumor. Microscopic examination of tissue biopsy revealed alternating areas of atypical cartilaginous tissue corresponding to the structure of chondrosarcoma 1-2 cm, solid proliferates of atypical fibroblast-like cells and areas of atypical and fibroblastic tissue containing elements of atypical osteogenesis. Periosteally - randomly oriented bone fragments at the place of the cortical plate, as well as impressions of the lower metaphysis of the thigh and the upper metaphysis of the tibia, near the knee joint.
The immunohistochemical examination showed a clear differential diagnosis of the existing CD99-positive tumor cells (DAKO, clone 12E7). Some cells were positive for SATB2 (Cell Marque, clone EP281); tumor cells were negative for S-100 - SOX-10. The histological picture and immunophenotype of the tumor cells correspond to chondroblastic osteosarcoma.
Osteosarcoma with genetic, metabolic and aplastic features developing in the setting of a comorbid background significantly complicates diagnosis and requires certain changes in the treatment tactics of CFRD (correction of prophylactic and basic therapy, metabolic and toxic disorders, including those caused by chemotherapy).
The research was carried out in accordance with the principles of the Helsinki Declaration. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
References
Baumhoer D, Böhling TO, Cates JMM et al. (2020). Osteosarcoma. In: WHO Classification of Tumours Soft Tissue and Bone Tumours. 5th ed. The WHO Classification of Tumours Editorial Board (Ed), IARC Press: 403.
Bukhari SIA, Truesdell SS, Vasudevan S. (2018). Analysis of MicroRNA-Mediated Translation Activation of In Vitro Transcribed Reporters in Quiescent Cells.Cellular Quiescence. Methods in Molecular Biology. Humana Press, New York, NY: 1686. URL: https://doi.org/10.1007/978-1-4939-7371-2_18; PMid:29030826 PMCid:PMC5733632
Demianyshyna VV. (2020). Clinical course of cystic fibrosis in children. «Reports of Vinnytsia National Medical University». 2 (24): 227-231. https://doi.org/10.31393/reports-vnmedical-2020-24(2)-05
Dockendorff TC, Labrador M. (2018). The Fragile X Protein and Genome Function. Mol. Neurobiol. 56 (1): 711-721. https://doi.org/10.1007/s12035-018-1122-9; PMid:29796988
Dudnyk V, Demianyshyna V. (2018). The level of the antimicrobial peptide cathelicidin in children with cystic fibrosis. In: Medical sciences: develpoment prospects in countries of Europe at the beginning of the third Milennium. Collective monograph. Riga: Izdevnieciba «Baltija Publishing»: 134-147.
Dudnyk V, Demianyshyna V. (2020). Assessment of severity of cystic fibrosis in children depending on the vitamin D status. Journal of Education, Health and Sport. 10 (9): 561-568. https://doi.org/10.12775/JEHS.2020.10.09.068
Dudnyk VM, Rudenko GM, Demianyshyna VV. (2017). Clinical characterization of children with cystic fibrosis. Reports of morphology. 1 (23): 73-76.
Dumortier C, Danopoulos S, Velard F, Al Alam D. (2021). Bone Cells Differentiation: How CFTR Mutations May Rule the Game of Stem Cells Commitment? Front. Cell Dev. Biol: 9. https://doi.org/10.3389/fcell.2021.611921; PMid:34026749 PMCid:PMC8139249
Haston CK, Li W, Li A et al. (2008). Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulatordefi cient mice. Am. J. Respir. Crit. Care Med. 177: 309-315. https://doi.org/10.1164/rccm.200705-659OC; PMid:18006890
King SL, Topliss DJ, Kotsimbos T et al. (2005). Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor. Eur. Respir. J. 25: 54-61. https://doi.org/10.1183/09031936.04.00050204; PMid:15640323
Kumar R, Kumar M, Malhotra K, Patel S. (2018). Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment. Curr Oncol Rep. 20: 13. https://doi.org/10.1007/s11912-018-0658-1; PMid:29492676
Le Heron L, Guillaume C, Velard F et al. (2010). Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. J. Cyst. Fibros. 9: 69-72. https://doi.org/10.1016/j.jcf.2009.11.005; PMid:20005786
Mirabello L, Zhu B, Koster R et al. (2020). Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. JAMA Oncol. 6: 724.
National Cancer Registry of Ukraine. (2020-2021). Cancer in Ukraine. Bulletin of the National Cancer Registry of Ukraine No. 23. URL: http://www.ncru.inf.ua/publications/BULL_23/index_e.htm.
Olesen HV, Drevinek P, Gulmans VA et al. (2020). Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome. J Cyst Fibros. 19: 321. https://doi.org/10.1016/j.jcf.2019.10.009; PMid:31680042
Prentice BJ, Ooi CY, Strachan RE et al. (2019). Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis. J Cyst Fibros. 18: 869. https://doi.org/10.1016/j.jcf.2019.03.010; PMid:31036487
Rayas MS, Hughan KS, Javaid R et al. (2020). 1788-P: Islet Function in Youth with Cystic Fibrosis with and without Liver Disease. Diabetes. 69: 1788. https://doi.org/10.2337/db20-1788-P
Shead EF, Haworth CS, Condliffe AM et al. (2007). Cystic fibro sis transmembrane conductance regulator (CFTR) is expressed in human bone. Thorax. 62: 650-651. https://doi.org/10.1136/thx.2006.075887; PMid:17600296 PMCid:PMC2117234
Smeland S, Bielack SS, Whelan J et al. (2019). Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 109: 36. https://doi.org/10.1016/j.ejca.2018.11.027; PMid:30685685 PMCid:PMC6506906
Zhang C, Morimoto LM, de Smith AJ et al. (2018). Genetic determinants of childhood and adult height associated with osteosarcoma risk. Cancer. 124: 3742. https://doi.org/10.1002/cncr.31645; PMid:30311632 PMCid:PMC6214707
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Ukrainian Journal of Perinatology and Pediatrics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “Ukrainian Journal of Perinatology and Pediatrics” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license(СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
